AbbVie Inc. (ABBV) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbbVie Inc.

    NYSE: ABBV · Real-Time Price · USD
    220.68
    2.14 (0.98%)
    At close: Sep 26, 2025, 3:59 PM
    220.81
    0.06%
    After-hours: Sep 26, 2025, 07:53 PM EDT

    AbbVie Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 5.52B 12.81B 9.2B 9.75B
    Short-Term Investments
    		 31M 2M 28M 84M
    Long-Term Investments
    		 279M 304M 241M 277M
    Other Long-Term Assets
    		 9.14B 8.51B 5.57B 4.88B
    Receivables
    		 10.92B 11.15B 11.25B 9.98B
    Inventory
    		 4.18B 4.1B 3.58B 3.13B
    Other Current Assets
    		 4.93B 4.93B 4.4B n/a
    Total Current Assets
    		 25.58B 33B 28.46B 27.93B
    Property-Plant & Equipment
    		 5.13B 4.99B 4.93B 5.11B
    Goodwill & Intangibles
    		 95.02B 87.9B 99.59B 108.33B
    Total Long-Term Assets
    		 109.58B 101.71B 110.34B 118.6B
    Total Assets
    		 135.16B 134.71B 138.81B 146.53B
    Account Payables
    		 2.94B 3.69B 2.93B 2.88B
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 6.8B 7.19B 4.3B 12.67B
    Other Current Liabilities
    		 27.01B 25.16B 20.93B 17.85B
    Total Current Liabilities
    		 38.75B 37.84B 29.54B 35.19B
    Long-Term Debt
    		 60.34B 52.17B 59.12B 64.16B
    Other Long-Term Liabilities
    		 24.38B 24.91B 23.4B 22.02B
    Total Long-Term Liabilities
    		 93.05B 86.47B 91.98B 95.9B
    Total Liabilities
    		 131.8B 124.31B 121.52B 131.09B
    Total Debt
    		 67.84B 60.12B 64.19B 77.58B
    Book Value
    		 3.36B 10.4B 17.29B 15.44B
    Book Value Per Share
    		 1.90 5.88 9.76 8.72
    Common Stock
    		 18M 18M 18M 18M
    Retained Earnings
    		 -7.9B -1B 4.78B 3.13B
    Comprehensive Income
    		 -1.93B -2.31B -2.2B -2.9B
    Shareholders Equity
    		 3.33B 10.36B 17.25B 15.41B
    Total Investments
    		 310M 306M 269M 361M

    Add to Watchlist